$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

3D‐Cell Spotter Cooperated High‐Throughput Screening (HTS) for Estimating Targeted Drugs in Breast Cancer Cells

Advanced therapeutics, v.6 no.2, 2023년, pp.2200161 -   

Lee, Sang‐Yun (Department of Biomedical Engineering Gachon University Seongnam 13120 Republic of Korea) ,  Hwang, Hyun Ju (Central R & D Center, Medical & Bio Decision (MBD) Co., Ltd Suwon 16229 Republic of Korea) ,  Lee, Dong Woo (Department of Biomedical Engineering Gachon University Seongnam 13120 Republic of Korea)

Abstract AI-Helper 아이콘AI-Helper

AbstractA 3D‐cell spotter is developed to maximize the efficiency of 3D cell‐based high‐throughput screening (3D‐HTS). The performance of 3D‐HTS is verified through heatmap analysis for distinguishing responses to targeted drugs according to the expression of HER2 ...

참고문헌 (38)

  1. Pampaloni, Francesco, Reynaud, Emmanuel G., Stelzer, Ernst H. K.. The third dimension bridges the gap between cell culture and live tissue. Nature reviews. Molecular cell biology, vol.8, no.10, 839-845.

  2. Ravi, Maddaly, Paramesh, V., Kaviya, S.R., Anuradha, E., Solomon, F.D. Paul. 3D Cell Culture Systems: Advantages and Applications. Journal of cellular physiology, vol.230, no.1, 16-26.

  3. Booij, Tijmen H., Price, Leo S., Danen, Erik H.J.. 3D Cell-Based Assays for Drug Screens: Challenges in Imaging, Image Analysis, and High-Content Analysis. SLAS discovery : advancing life sciences R & D, vol.24, no.6, 615-627.

  4. Candini, Olivia, Grisendi, Giulia, Foppiani, Elisabetta Manuela, Brogli, Matteo, Aramini, Beatrice, Masciale, Valentina, Spano, Carlotta, Petrachi, Tiziana, Veronesi, Elena, Conte, Pierfranco, Mari, Giorgio, Dominici, Massimo. A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology. Scientific reports, vol.9, 7154-.

  5. Langhans, Sigrid A.. Three-Dimensional in Vitro Cell Culture Models in Drug Discovery and Drug Repositioning. Frontiers in pharmacology, vol.9, 6-.

  6. Chramiec, Alan, Teles, Diogo, Yeager, Keith, Marturano-Kruik, Alessandro, Pak, Joseph, Chen, Timothy, Hao, Luke, Wang, Miranda, Lock, Roberta, Tavakol, Daniel Naveed, Lee, Marcus Busub, Kim, Jinho, Ronaldson-Bouchard, Kacey, Vunjak-Novakovic, Gordana. Integrated human organ-on-a-chip model for predictive studies of anti-tumor drug efficacy and cardiac safety. Lab on a chip, vol.20, no.23, 4357-4372.

  7. Wang, Yichun, Jeon, Hyunsu. 3D cell cultures toward quantitative high-throughput drug screening. Trends in pharmacological sciences, vol.43, no.7, 569-581.

  8. Press, Michael F, Lenz, Heinz-Josef. EGFR, HER2 and VEGF Pathways : Validated Targets for Cancer Treatment. Drugs, vol.67, no.14, 2045-2075.

  9. Cohen, Bruce D., Kiener, Peter A., Green, Janell M., Foy, Linda, Fell, H. Perry, Zhang, Ke. The Relationship between Human Epidermal Growth-like Factor Receptor Expression and Cellular Transformation in NIH3T3 Cells. The Journal of biological chemistry, vol.271, no.48, 30897-30903.

  10. Schlessinger, Joseph. Ligand-Induced, Receptor-Mediated Dimerization and Activation of EGF Receptor. Cell, vol.110, no.6, 669-672.

  11. Yu, Jinfeng, Fang, Tong, Yun, Chengyu, Liu, Xue, Cai, Xiaoqing. Antibody-Drug Conjugates Targeting the Human Epidermal Growth Factor Receptor Family in Cancers. Frontiers in molecular biosciences, vol.9, 847835-.

  12. 10.1016/bs.acr.2020.04.001 

  13. Sheng, Q, Liu, J. The therapeutic potential of targeting the EGFR family in epithelial ovarian cancer. The British journal of cancer, vol.104, no.8, 1241-1245.

  14. Chen, Jun, Kinoshita, Taisei, Sukbuntherng, Juthamas, Chang, Betty Y., Elias, Laurence. Ibrutinib Inhibits ERBB Receptor Tyrosine Kinases and HER2-Amplified Breast Cancer Cell Growth. Molecular cancer therapeutics, vol.15, no.12, 2835-2844.

  15. J. Natl. Cancer Inst. Gao W. 106 2014 

  16. Wang, Lingzhi, Syn, Nicholas Li-Xun, Subhash, Vinod Vijay, Any, Yijia, Thuya, Win Lwin, Cheow, Esther Sok Hwee, Kong, Liren, Yu, Fenggang, Peethala, Praveen C., Wong, Andrea Li-Ann, Laljibhai, Hirpara J., Chinnathambi, Arunachalam, Ong, Pei Shi, Ho, Paul Chi-Lui, Sethi, Gautam, Yong, Wei Peng, Goh, Boon Cher. Pan-HDAC inhibition by panobinostat mediates chemosensitization to carboplatin in non-small cell lung cancer via attenuation of EGFR signaling. Cancer letters, vol.417, 152-160.

  17. LaBonte, Melissa J., Wilson, Peter M., Fazzone, Will, Russell, Jared, Louie, Stan G., El-Khoueiry, Anthony, Lenz, Heinz-Josef, Ladner, Robert D.. The Dual EGFR/HER2 Inhibitor Lapatinib Synergistically Enhances the Antitumor Activity of the Histone Deacetylase Inhibitor Panobinostat in Colorectal Cancer Models. Cancer research : the official organ of the American Association for Cancer Research, Inc, vol.71, no.10, 3635-3648.

  18. Lee, K.Y., Mooney, D.J.. Alginate: Properties and biomedical applications. Progress in polymer science, vol.37, no.1, 106-126.

  19. Lee, Sang-Yun, Doh, Il, Nam, Do-Hyun, Lee, Dong Woo. 3D Cell-Based High-Content Screening (HCS) Using a Micropillar and Microwell Chip Platform. Analytical chemistry, vol.90, no.14, 8354-8361.

  20. Lee, Sang-Yun, Teng, Yvonne, Son, Miseol, Ku, Bosung, Hwang, Hyun Ju, Tergaonkar, Vinay, Chow, Pierce Kah-Hoe, Lee, Dong Woo, Nam, Do-Hyun. Three-Dimensional Aggregated Spheroid Model of Hepatocellular Carcinoma Using a 96-Pillar/Well Plate. Molecules a journal of synthetic chemistry and natural product chemistry, vol.26, no.16, 4949-.

  21. Bonnans, Caroline, Chou, Jonathan, Werb, Zena. Remodelling the extracellular matrix in development and disease. Nature reviews. Molecular cell biology, vol.15, no.12, 786-801.

  22. 10.2174/138920112802501999 

  23. Oncol. Lett. Lv D. 6999 14 2017 

  24. Melissaridou, Styliani, Wiechec, Emilia, Magan, Mustafa, Jain, Mayur Vilas, Chung, Man Ki, Farnebo, Lovisa, Roberg, Karin. The effect of 2D and 3D cell cultures on treatment response, EMT profile and stem cell features in head and neck cancer. Cancer cell international, vol.19, 16-.

  25. Salinas-Vera, Yarely M., Valdés, Jesús, Pérez-Navarro, Yussel, Mandujano-Lazaro, Gilberto, Marchat, Laurence A., Ramos-Payán, Rosalio, Nuñez-Olvera, Stephanie I., Pérez-Plascencia, Carlos, López-Camarillo, César. Three-Dimensional 3D Culture Models in Gynecological and Breast Cancer Research. Frontiers in oncology, vol.12, 826113-.

  26. OncoTargets Ther. Nelson V. 135 6 2013 

  27. Diaz, Nills, Minton, Susan, Cox, Charles, Bowman, Tammy, Gritsko, Tanya, Garcia, Roy, Eweis, Ibrahim, Wloch, Marek, Livingston, Sandy, Seijo, Ed, Cantor, Alan, Lee, Ji-Hyun, Beam, Craig A., Sullivan, Daniel, Jove, Richard, Muro-Cacho, Carlos A.. Activation of Stat3 in Primary Tumors from High-Risk Breast Cancer Patients Is Associated with Elevated Levels of Activated Src and Survivin Expression. Clinical Cancer research : an official journal of the American Association for Cancer Research, vol.12, no.1, 20-28.

  28. Soria, J.-C., Cortes, J., Massard, C., Armand, J.-P., De Andreis, D., Ropert, S., Lopez, E., Catteau, A., James, J., Marier, J.-F., Beliveau, M., Martell, R.E., Baselga, J.. Corrections to “Phase I safety, pharmacokinetic and pharmacodynamic trial of BMS-599626 (AC480), an oral pan-HER receptor tyrosine kinase inhibitor, in patients with advanced solid tumors”. Annals of oncology : official journal of the European Society for Medical Oncology, vol.30, no.6, 1020-.

  29. Atalay, G., Cardoso, F., Awada, A., Piccart, M. J.. Novel therapeutic strategies targeting the epidermal growth factor receptor (EGFR) family and its downstream effectors in breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology, vol.14, no.9, 1346-1363.

  30. Zeng, Fanpu, Wang, Fang, Zheng, Zongheng, Chen, Zhen, Wah To, Kenneth Kin, Zhang, Hong, Han, Qian, Fu, Liwu. Rociletinib (CO-1686) enhanced the efficacy of chemotherapeutic agents in ABCG2-overexpressing cancer cells in vitro and in vivo. Acta pharmaceutica Sinica. B, vol.10, no.5, 799-811.

  31. J. Thorac. Dis. Carpenter R. L. 6 4 2012 

  32. Ann. Intern. Med. Maitland M. L. 145 2006 

  33. Amelia, Tasia, Kartasasmita, Rahmana Emran, Ohwada, Tomohiko, Tjahjono, Daryono Hadi. Structural Insight and Development of EGFR Tyrosine Kinase Inhibitors. Molecules : a journal of synthetic chemistry and natural product chemistry, vol.27, no.3, 819-.

  34. PLoS One Kim H. P. 6 4 2009 

  35. Breast Cancer Feldinger K. 7 9 2015 

  36. J. Chem. Theory Comput. Park J. 4 12 2016 

  37. Cancer Chemother. Pharmacol. Reardon D. A. 6 69 2012 

  38. Goudar, Ranjit K., Shi, Qing, Hjelmeland, Mark D., Keir, Stephen T., McLendon, Roger E., Wikstrand, Carol J., Reese, Elizabeth D., Conrad, Charles A., Traxler, Peter, Lane, Heidi A., Reardon, David A., Cavenee, Webster K., Wang, Xiao-Fan, Bigner, Darell D., Friedman, Henry S., Rich, Jeremy N.. Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibition. Molecular cancer therapeutics, vol.4, no.1, 101-112.

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로